208 related articles for article (PubMed ID: 21465242)
1. Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia.
Romón T; Mengod G; Adell A
Psychopharmacology (Berl); 2011 Sep; 217(2):231-8. PubMed ID: 21465242
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain.
Qin ZH; Zhang SP; Weiss B
Brain Res Mol Brain Res; 1994 Feb; 21(3-4):293-302. PubMed ID: 8170353
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
[TBL] [Abstract][Full Text] [Related]
4. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers.
Benneyworth MA; Roseman AS; Basu AC; Coyle JT
Neurosci Lett; 2011 Jan; 488(3):267-71. PubMed ID: 21094213
[TBL] [Abstract][Full Text] [Related]
5. Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex.
Xi D; Zhang W; Wang HX; Stradtman GG; Gao WJ
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1395-408. PubMed ID: 19435549
[TBL] [Abstract][Full Text] [Related]
6. The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention.
Pehrson AL; Bondi CO; Totah NK; Moghaddam B
Psychopharmacology (Berl); 2013 Jan; 225(1):31-9. PubMed ID: 22797703
[TBL] [Abstract][Full Text] [Related]
7. [Changes in expression levels of PV, GAD67 and KCC2 in the brain tissue of rats with schizophrenia induced by MK-801].
Liu Y; Tang YM; Zhang XH; Zhao JP
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):869-74. PubMed ID: 23146738
[TBL] [Abstract][Full Text] [Related]
8. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
9. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia.
Curley AA; Eggan SM; Lazarus MS; Huang ZJ; Volk DW; Lewis DA
Neurobiol Dis; 2013 Feb; 50():179-86. PubMed ID: 23103418
[TBL] [Abstract][Full Text] [Related]
10. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia.
Väisänen J; Ihalainen J; Tanila H; Castrén E
Cell Mol Neurobiol; 2004 Dec; 24(6):769-80. PubMed ID: 15672679
[TBL] [Abstract][Full Text] [Related]
11. Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin.
Turner CP; DeBenedetto D; Ware E; Stowe R; Lee A; Swanson J; Walburg C; Lambert A; Lyle M; Desai P; Liu C
Exp Brain Res; 2010 Mar; 201(3):479-88. PubMed ID: 19885653
[TBL] [Abstract][Full Text] [Related]
12. Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.
Georgiev D; Yoshihara T; Kawabata R; Matsubara T; Tsubomoto M; Minabe Y; Lewis DA; Hashimoto T
Schizophr Bull; 2016 Jul; 42(4):992-1002. PubMed ID: 26980143
[TBL] [Abstract][Full Text] [Related]
13. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
Hashimoto T; Volk DW; Eggan SM; Mirnics K; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2003 Jul; 23(15):6315-26. PubMed ID: 12867516
[TBL] [Abstract][Full Text] [Related]
14. Prenatal administration of lipopolysaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brain.
Basta-Kaim A; Fijał K; Ślusarczyk J; Trojan E; Głombik K; Budziszewska B; Leśkiewicz M; Regulska M; Kubera M; Lasoń W; Wędzony K
Neuroscience; 2015 Feb; 287():78-92. PubMed ID: 25528062
[TBL] [Abstract][Full Text] [Related]
15. Parvalbumin Loss Following Chronic Sub-Anesthetic NMDA Antagonist Treatment is Age-Dependent in the Hippocampus: Implications for Modeling NMDA Hypofunction.
Honeycutt JA; Chrobak JJ
Neuroscience; 2018 Nov; 393():73-82. PubMed ID: 30296474
[TBL] [Abstract][Full Text] [Related]
16. Neuro-behavioral effects after systemic administration of MK-801 and disinhibition of the anterior thalamic nucleus in rats: Potential relevance in schizophrenia.
López Hill X; Richeri A; McGregor R; Acuña A; Scorza C
Brain Res; 2019 Sep; 1718():176-185. PubMed ID: 31071305
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine.
Bullock WM; Bolognani F; Botta P; Valenzuela CF; Perrone-Bizzozero NI
Neurochem Int; 2009 Dec; 55(8):775-82. PubMed ID: 19651169
[TBL] [Abstract][Full Text] [Related]
18. Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801.
Bygrave AM; Masiulis S; Nicholson E; Berkemann M; Barkus C; Sprengel R; Harrison PJ; Kullmann DM; Bannerman DM; Kätzel D
Transl Psychiatry; 2016 Apr; 6(4):e778. PubMed ID: 27070406
[TBL] [Abstract][Full Text] [Related]
19. Is the acute NMDA receptor hypofunction a valid model of schizophrenia?
Adell A; Jiménez-Sánchez L; López-Gil X; Romón T
Schizophr Bull; 2012 Jan; 38(1):9-14. PubMed ID: 21965469
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
